Trading Options with an Edge
Select Page

VCEL

Search by
TICKER SYMBOL

Vericel Corp

Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing

49.55

-1.45

(-2.843%)

Volume:

0

52 week range:

17.78 - 68.94

Market Cap:

2.311B

Company Description:

Vericel is a leader in advanced therapies for the sports medicine and severe burn care markets. The company markets two cell therapy products in the United States. MACI® (autologous cultured chondrocytes on porcine collagen membrane) is an autologous cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. Epicel® (cultured epidermal autografts) is a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to 30% of total body surface area. The company also holds an exclusive license for North American rights to NexoBrid®, a registration-stage biological orphan product for debridement of severe thermal burns.